Reuters logo
BRIEF-Inozyme Pharma raises $49 million in a Series A financing
November 15, 2017 / 12:25 PM / 4 days ago

BRIEF-Inozyme Pharma raises $49 million in a Series A financing

Nov 15 (Reuters) - Inozyme Pharma:

* Raises $49 million in a Series A financing to develop therapies for rare diseases affecting soft tissues and bone

* Financing was led by Longitude Capital, and included participation from New Enterprise Associates, Novo Ventures and Sanofi Ventures​ Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below